In human genetic studies, the availability of specimens to serve as sources for genomic DNAs could often be quantitatively limited in either the number of samples or the amount of each sample or both. Blood, cultured cell lines, biopsies and autopsies are the main sources of DNA. Blood is the primary source. Serum is often collected because it provides a source in which a variety of marker molecules can be measured in the course of various diseases. Recently, serum was used for polymerase chain reaction (PCR) detection of viral DNA (1, 4, 8) . To tap on potential banks of sera as sources of genomic DNA, Martin et al. (7) described a time-consuming (>24 h) procedure in which they were able to isolate DNA from about 2000 µ L serum. Recently, Fowke et al. ( 3) used a commercially available DNA purification kit to bind DNA from serum to silica gel matrix and then to elute the DNA for PCR amplification. In their study, the DNA from 50 µ L serum was used as template in only one PCR, and the amplified PCR product was 242 bp. After our present manuscript was completed, a report (9) describing a microwave irradiation method was published that shows the maximum size of PCR products is up to 442 bp when the isolated DNA is used as template. In our report, we describe a method for preparing genomic DNA from serum that: (i) is simple and inexpensive, (ii) requires a small amount of serum (20 µ L), (iii) is less damaging to DNA (fragments up to 4 kb can be amplified), and (iv)gives relatively high yield of DNA, making it applicable to multiple genetic marker analysis from limited amounts of serum.
Twenty to eighty microliters of serum are blotted onto Nitrocellulose Membranes (Stratagene, La Jolla, CA, USA), and cells on the membrane are lysed by placing the membrane cellside up, on a sheet of 3MM paper (Whatman, Clifton, NJ, USA) soaked with 0.5 M NaOH/1.5 M NaCl for 5 min. The lysate on the membrane is neutralized by placing the membrane on a sheet of 3MM paper soaked with 1.5 M NaCl/0.5 M Tris-HCl (pH 7.5) for 5 min, and subsequently for 3 min on a sheet of 3MM paper soaked with 0.2 M Tris-HCl (pH 7.5). After being air-dried at room temperature, the membrane is cut into discs, each carrying one serum sample. Each disc is transferred into a microcentrifuge tube containing 50 µ L of distilled (d)H 2 O, and the DNA is eluted into dH 2 O by boiling for 5 min. The eluent is phenolextracted and ethanol-precipitated without any carrier. The DNA pellet is dried and dissolved in 50 µ L dH 2 O at 65°C for 10 min. The DNA solution is cleared of any debris by centrifugation at 16 000 × g , 4°C for 6 min.
The quality of the genomic DNA prepared from serum using the micro-extraction procedure described above was compared to the quality of: (i) DNA prepared from whole-blood specimens as described previously (2) and noted as control (C) in Figures 1 and 2 , and (ii) DNA prepared from 250 µ L of serum by a modified proteinase K/sodium dodecyl sulfate (SDS) lysis (miniprep) method and noted as P in Figure 1 . Briefly, 250 µ L of serum are treated with proteinase K (1.7 mg/mL) and 5% SDS at 65°C for 1 h and then heated at 95°C for 10 min to inactivate the proteinase K. The lysate is phenol-extracted and ethanol-precipitated. The DNA pellet, after centrifugation at 16 000 × g , 4°C for 15 min, is dissolved in 50 µ L of dH 2 O.
A long PCR amplification was conducted to demonstrate the maximum size of DNA fragments that can be amplified from the micro-extracted DNA. The target DNA sequence is human pulmonary surfactant (SP-) B gene (6) . Long PCR is performed using the Expand ™ Long Template PCR System (Boehringer Mannheim, Indianapolis, IN, USA). The PCR template is 5 µ L of the micro-extracted DNA [nitrocellulose (N) method], 2 µ L of miniprepped DNA [modified proteinase K/SDS (P) method] and 100 ng control (C) DNA from blood (2) . The PCR procedure and primer used are as previously described (6) . The PCR conditions are: an initial denaturing step at 95°C for 2 min; 10 cycles at 95°C for 30 s, 55°C for 1 min and 68°C for 10 min; 25 cycles at 95°C for 30 s, 58°C for 1 min and 68°C for 12 min; and a final extension step at 68°C for 20 min. Figure 1A shows the results of long PCR. All five target SP-B sequences are amplified very well from control (C) DNA. However, only the two shorter fragments (3789 and 2398 bp) are amplified from the microextracted (N) and miniprepped (P) DNA. These findings indicate that the micro-extracted DNA molecules from serum are not intact with either procedure (N or P) compared with those prepared with procedure C. However, in human genetic studies where PCR is widely used, the target sequences are generally smaller than 4 kb. Therefore, the quality of the DNA obtained from the micro-extraction method can fulfill this requirement, because PCR amplification of fragments with sizes of approximately 4 kb is possible.
Next, we amplified two smaller SP-B gene fragments (765 and 567 bp) from DNA micro-extracted from 5 serum samples and one control DNA ( Figure 1B) . The PCR primers and PCR preparation are described by Lin et al. (6) . The PCR profile conditions are: one cycle at 95°C for 2 min; 30 cycles at 95°C for 30 s, 55°C for 1 min, 70°C for 1 min; and 1 cycle at 70°C for 5 min.
The results ( Figure 1B) show that the two targeted DNA sequences are amplified equally well among all the DNA templates used. We conclude that the quality of the micro-extracted DNA is sufficiently good to be used as template to amplify target sequences of ≤ 1 kb using regular PCR and to amplify target sequences of ≤ 4 kb using long PCR.
To further test the quality of the genomic DNA from the micro-extraction method, we performed genotyping of DNA from 4 samples using 2 different types of genetic markers. One is a single-nucleotide polymorphism (SNP) with a C/A substitution in the SP-B gene (our unpublished data), and the other is a microsatellite marker, (GATA) n repeats (5). For the C/A substitution, we used the PCR-based converted restriction fragment-length polymorphism (cRFLP) method. The DNA sequence flanking the C/A substitution is amplified with primers 550 and 95a (6) . One microliter of the 550/95a PCR product is used as template for nested PCR amplification with primers 556 and 95A to amplify a 167-bp target sequence. The nested PCR amplification is performed: (i) to convert the C/A site to Apa LI enzyme recognition site by the modified primer 556 (note: the modified primer contains a mismatch at the third nucleotide from the 3 ′ end), (ii)to enhance the specificity of the PCR amplification and (iii) to increase the yield of the PCR products. Five microliters of each PCR product are digested with Apa LI, and the digested PCR product is separated by 8% polyacrylamide gel electrophoresis (PAGE). The PCR product from the A allele is cut by Apa LI and becomes two fragments, 146 and 21 bp, whereas the product from the C allele is not cut by Apa LI and therefore remains a 167-bp fragment. Figure 24 shows the 167-and 146-bp fragments after separation on an 8% PAGE gel, whereas the 21-bp For the microsatellite marker analysis, a DNA segment is amplified with primers 564 and 565 flanking the (GATA) n marker. Primer 564 is labeled with [ 32 P]ATP. Two microliters of micro-extracted DNA or 50 ng of control (C) DNA are used as template for PCR. The PCR amplification and gel separation of PCR products are described by Kala et al. (5) . The results are shown in Figure 2B . Clearly, both total and allelic PCR products are different among these 5 serum samples. The amount of DNA prepared from 20 µ L serum is small, and it cannot be used for concentration measurements. Therefore, because differences in the amount of serum DNA used as template for PCR from different serum samples can exist, the intensity of PCR products may differ among these samples. Differences in the intensity among alleles of a given sample may be explained by allele preferential amplification. However, the genotype of the 5 serum samples tested here can be clearly scored as follows: the alleles in ( In summary, genomic DNA prepared from small amounts of serum using the micro-extraction procedure can serve as template to amplify DNA segments as large as 3789 bp. Furthermore, these amplified PCR products are of similar quality as the control DNA when used in genotype analysis either with cRFLP-PCR-based bi-allelic markers or with microsatellite markers. The combination of genomic DNA micro-extraction from small amounts of serum and PCR-based genotyping methods provides a powerful tool for genetic studies. Based on our present results, 100 µ L of serum could serve as a genomic DNA source for genotype analysis of 20 bi-allelic markers and 50 microsatellite markers. Therefore, the present genomic DNA extraction method opens up possibilities for use of existing specimens in, for example, disease-causing gene identification and mutation screening, especially when genomic DNA sources and amounts of each sample are limited. It could also be used in genetic diagnosis with single or multiple genetic markers in cases of limited availability of serum samples.
